We have begun a measured genotype approach to the genetic analysis of lipid and lipoprotein variability. This approach enables one to simultaneously estimate the frequencies and effects of alleles a t specific loci along with the residual polygenetic variance component. I n this study we consider the contribution of three common alleles a t the locus coding for apolipoprotein E to interindividual variation of total cholesterol, betalipoprotein, and triglyceride levels. A sample of 102 nuclear families consisting of 434 individuals was studied. The frequencies of the €2, €3, and €4 alleles in this sample are 0*137,0.740, and 0123, respectively. I n separate analyses of cholesterol and betalipoprotein levels, a complete model that includes the effects of the six apo E genotypes, unmeasured polygenes, and individual specific environmental effects fits these data significantly better than a reduced model that does not include the effects of the apo E polymorphism or a reduced model that does not include the effects of polygenes. On the average the €2 allele lowers total cholesterol and betalipoprotein levels by 0425 mmol/l and 0.81 1 units, respectively. The €4 allele is associated with an average increase of these phenotypes by 0.255 mmol/l and 0.628 units, respectively. Simultaneous estimates of the interindividual variability of total cholesterol levels attributable to the apo E polymorphism and to residual polygenic effects are 8 % and 56 % , respectively. For betalipoprotein levels, we simultaneously estimate these values to be 7 yo and 42 Yo, respectively. A reduced model including the effects of polygenes but not the effects of the apo E polymorphism fitted the triglyceride data as well as the complete model. The estimate of the fraction of interindividual variability associated with polygenetic effects was 26.5 %. We review our present understanding of the genetic architecture underlying variability of cholesterol levels in the population a t large and infer that the majority of the genetic variability may be accounted for by polymorphic gene loci with moderate effects on cholesterol levels.
INTRODUCTION
Biometrical genetic studies have established that a significant proportion of the interindividual variability of many quantitative phenotypes is attributable to polygenetic differences among individuals. These studies assume that there are a large number of unlinked loci (polygenes) with small, independent and additive effects contributing to the phenotype of interest. This assumption has often been accepted as a biological fact. Findings from limited experimental animal work suggest that this assumption may not be valid, at least for some traits (Thompson, 1975; Thompson & Thoday, 1979; Hopkinson et al. 1964) . Their work suggests that relatively few gene loci may be responsible for the genetic component of quantitative phenotypic variability. Direct estimation of the frequencies and effects of alleles a t specific loci is required to elucidate the genetic architecture (number of loci, frequency of their alleles, size of their effects and type of loci) of a quantitative phenotype.
In order to investigate the frequencies, effects, and the contribution to phenotypic and polygenetic variance of a specific locus, we have implemented a ' measured genotype ' approach to the genetic analysis of a quantitative phenotype (Boerwinkle et al. 1 9 8 6~) . This approach uses measured genetic variability a t loci that are physiologically involved in the determination of a quantitative phenotype. Lipid metabolism is a system that allows one to pursue a measured genotype approach to genetic variability. Biometrical genetic studies have demonstrated that a significant proportion of the variability of many lipid and lipoprotein phenotypes in the population a t large is attributable to genetic differences among individuals (Sing & Orr, 1978 ; Rao et a1 1979). Applications of this approach by ourselves (Sing & Davignon, 1985; Boerwinkle et al. 19863 ) and others (Uterman et al. 1979 ; Robertson & Cumming, 1985) , have utilized samples of unrelated individuals and primarily investigated the frequencies and effects of alleles at only the. measured locus.
By sampling groups of related individuals and measuring the value of a quantitative phenotype and the genotype at a single locus, one can directly partition the overall genetic variability into a proportion attributable to the measured single locus and a proportion due to the segregation of unmeasured residual polygenes. The logic and methods that enable one to simultaneously estimate the frequencies and effects of the alleles at a single measured locus, and a residual polygenetic variance component, have been presented in the first paper in this series (Boerwinkle et al. 1 
8 6~) .
In this paper, we simultaneously estimate the frequencies and effects of a single measured locus, and the residual polygenetic variance in order to begin to investigate the role of the apolipoprotein (apo) E polymorphism in determining the genetic architecture underlying quantitative phenotypic variability in three measures of lipid metabolism.
Many of the phenotypes that are measures of lipid metabolism, such as total serum cholesterol levels. are associated with one's relative risk of coronary artery disease ). Genetic loci involved in lipid metabolism have been identified and allelic variability a t many of these loci has been described (reviewed in Breslow, 1985) . I n this study we are continuing our efforts t o understand the genetic variability underlying lipid and lipoprotein quantitative phenotypes. We have measured total cholesterol, betalipoprotein and triglyceride levels, and scored the apo E polymorphism on a sample of 102 nuclear families consisting of 434 individuals. Apo E has an important role in lipid metabolism as a structural component of VLDL, a ligand for lipoprotein receptors and is involved in the conversion of VLDL to LDL by lipoprotein lipase. Apo E is also polymorphic (Ctermann et al. 1977 ; Zannis & Breslow, 1981; Bouthillier P t al 1983). There are three common isoforms of apo E designated E2, E3 and E4 which are distinguishable by isoelectric focusing. The three alleles that code for these isoforms combine to produce six possible genotypes (€212, €213, €214, €313, €314 and €414). We wish to investigate the contribution of the apo E polymorphism to the determination of the polygenetic variability of cholesterol. betalipoprotein and triglyceride levels. These analyses are the first efforts to directly partition the contribution of a single polymorphic locus out of the polygenetic variance for these quantitative phenotypes.
METHODS

Samples considered
The analyses reported here were carried out on a sample of 102 nuclear families obtained as part of a large population based preventive medicine study in Nancy, France (Houot et al. 1985) . The families were sequentially sampled a t the Centre for Preventive Medicine in Nancy between August 20, 1983 and September 12, 1983. These 102 families consist of 434 individuals (204 parents and 230 children). Only criteria that do not allow routine phlebotomy were reasons for exclusion. There are no individuals in this sample recorded as using antihyperlipidemic drugs. To compare adults and children for the effects of the apo E polymorphism on lipid and lipoprotein variability, the 204 parents and the youngest child from each family were considered.
Laboratory procedures
Blood was collected into heparin containing tubes between 8.00 a.m. and 9.00 a. A 2 ml aliquot of plasma from each subject was sent to Ann Arbor on dry ice for typing the apo E polymorphism by two-dimensional gel electrophoresis. Plasma samples were kept a t -80 "C until they were electrophoresed. Two microlitres of plasma were used for each two-dimensional gel. The two-dimensional electrophoresis was carried out as previously described (Nee1 et al. 1984; Boerwinkle et al. 1986b ). First-dimension electrophoresis utilized ampholytes (LKB) with a pH range of 3.5 to 10 and was carried out for 15 h a t 1200 V and 2 h a t 1500 V. The slab gels contained a 110-130 g/1 acrylamide gradient. Following electrophoresis, the gels were intially stained with Coomassie brilliant blue and then were subsequently silver stained by the method of Sammons et al. (1981) . The three isoforms of apo E appear as separate spots on the gel. The two-dimensional electrophoretograms reported here were typed concordantly and independently by two experienced observers. Typing of a gel was done without knowledge of the individual's lipid and lipoprotein levels, or the apo E type of his or her relatives.
Statistical methods
Before investigating the effects of the apo E polymorphism on the lipid and lipoprotein phenotypes, multiple linear regression was used to adjust these traits for the effects of variation in gender, generation, hormone use in women, age within generation, height and weight. The model and analytical methods for estimating from pedigree data the frequencies and effects of the apo E polymorphism, the polygenetic variance component, and a nongenetic variance component were given in the first paper of this series (Boerwinkle et al. 1 9 8 6~) .
Briefly, we model the adjusted lipid or lipoprotein level of the ith individuals as where p, is the mean of the j t h genotype at a single locus, Gi is the deviation from pj due to the polygenotype of the ith individual, and Ei is the deviation from pj due to totality of all environmental effects and measurement errors specific to the ith individual. The polygenotype is assumed to be determined by a large number of unlinked loci each with small additive allelic effects that combine independently and additively. G and E are random effects that are assumed to be independent and normally distributed, each with a mean of zero and variance a& and af, respectively. The likelihood of observing the measured single locus genotypes and phenotypes of a family can be partitioned into the likelihood of observing the measured genotypes times the likelihood of the phenotypes of the family members conditional on their measured single locus genotypes. (1) the apo E polymorphism has no effect on lipid and lipoprotein levels; (2) the residual polygenetic variance component is (qua1 to zero: and (3) a subset of the apo E genotype specific means are equal to one another. The subsets of means set equal t o one another were chosen based on the results of previous analyses on the effects of the apo E polymorphism on these and other phenotypes (Menzrl P t al. 1983 . Robertson & Cumming. 1985 Sing & Davignon, 1985; Boerwinkle et al. 19X6b j From these studies, we hypothesize that the mean cholesterol and betalipoprotein levels of individuals with the sZ/Z and c 2 / 3 genotypes were equal to one another, as are the mean levclh of individuals ~i t h the d / 4 , e 3 / 4 and e 4 / 4 genotypes. No a priori hypotheses were formulated about the effects of the apo E polymorphism on triglyceride levels. 
(3)
The first method of estimating the variance contribution that we considered simply substitutes parameters of the model in equation (2) with parameter estimates. This estimator is biased (Boerwinkle & Sing, 1986) . It will, on the average, overestimate the variance contribution of the single measured locus. For a sample of unrelated individuals, the bias correction is equal
, where J is the number of genotype classes and n is the number of unrelated individuals in the sample. For a sample of related individuals, the expectation of the magnitude of the bias has not been derived. We took two approaches in formulating a bias corrected estimator. We set n equal to the number of parents in the sample (the second method) and also set n equal to the total sample size (the third method). The fourth method considered estimates the variance contribution of the single locus by the increase in the estimated polygenetic variance component when the measured single locus effects are not parameterized in the model over the estimated variance component when the measured single locus effects are included in the model. 
RESULTS
Descriptive statistics for the family members are given in Table 1 . One 'family' had no children and the other families had an average of 2.28 children per family. As expected, the fathers of these nuclear families were older, taller, heavier, and had higher lipid and lipoprotein levels than their spouses. The mcan levels of the measured concomitants. and lipid and lipoprotein phenotypes were higher for parents than for children. For children, the mean levels of the measured concomitants and the lipid and lipoprotein phenotypes were comparable bctmeen genders 35 o/o of the interindividual variability in plasma cholesterol levels in this sarriplc could be accounted for by a linear relationship with generation, gender, hormone use among females, age, height and weight. This value is 41 74 and 24% for betalipoprotein and triglj cerides, respectively. Adjustment by linear regression for variation in these concomitant variables results in a statistically significant ( P < 0.01) reduction in variance for each of the three phenotypes.
Thc relative frequencies of the six apo E genotypes for each gender by generation group are also given in Table 1 . These relative frequencies are not significantly heterogeneous among these groups. lrsing the genotype counts from the parents, the estimated relative frequencies of the 62. e 3 and €4 alleles in the population at, large are0.137 (k0*00029), 0-740 (k0.00098) and 0.123 (+OW080), respectively. The relative frequencies of the €2, €3 and €4 alleles in the children are 0.1 11 (i0*00022), 0761 (&000089 and 0.128 (+000077), respectively. The genotype counts of the parcnts and the children do not differ significantly from those expected assuming Hardy-M'einberg equilibrium. Using a chi-square goodness-of-fit test (Vogel & Motulsky, 1979), the wgregation of the apo E genotypes among the children in the families does not differ significantly from the ratios expected under a model of autosomal codominant inheritance N ith Mendelian segregation probabilities.
The maximum likelihood estimates of the apo E genotype specific means, the polygenetic variance component, and the individual specific environmental variance component for various modcls are given in Table 2 . Table 2 also presents the log, likelihood of the parameter estimates of t h e model given the quantitative phenotypes and the apo E genotypes and the difference bcitwcen the log, likelihood of the complete model and each of the reduced models.
For total plasma cholesterol levels, the complete model fitted the data significantly better than a model with no polygenes ( P < 0.01) and a model with no effect of the upo E polymorphism ( P < 0.01). The rrduced model that groups genotype specific means based on a priori hypotheses. fitted the data as well as the complete model. Individuals with the E2/2 genotype had the lowest average cholesterol in the sample and individuals with the €414 genotype had the highest average cholesterol in the sample. Individuals with apo E genotypes e2/2 and ~2 / 3 had lower average cholesterol levels than the grand mean, and individuals with apo E genotypes ~2 / 1 , ~3 / 4 and ~4 / 4 had higher average cholesterol levels than the grand mean. €313 individuals had an average cholesterol level close t o the grand mean. For the complete model, 56 0,; of the phenotypic variance within apo E genotype class was attributable to residual polygenetic effects. M'hen there was no apo E effect parameterized in the model, the polygenetic variance contribution to the variance of cholesterol levels was 58 yo.
The complete model describing the distribution of betalipoprotein levels also fitted these data significantly better than a model with no polygenes ( P < O O l ) , significantly better than a model Thc estimated variances, covariances and correlations of, and between, the parameter estiniatc~ of the completcl model for our analysis of cholesterol levels are given in Table 3 . The average magnitude of the standard deviation of the estimates of the single locus genotype means is on]) 0.181. JItlasuretl genotype analyses typically yield smaller variances of the parameter estimates than unmeasured genotype analyses, such as complex segregation analysis (Boerwinkle. 1985). The variances of the variance component estimates are also small. The covariances and wrwlations between the estimated genotype specific means and variance components are ZCI'O hwause ofthc h1oc.k diagonal structure of the information matrix (Boerwinkle et al. 1 9 8 6~) . 'I'hc c.orrc.lations betu cen the estimates of the genotype specific means are all positive and low. T h r c*orr.clation bet\\ cen the estimates of the residual polygenetic and individual specific nongcirit,tic. varianw components is negative and quite large. We attribute this to a fixed within up0 E yenotyp(~ phrnotypic variance in the sample that can be partitioned into the two variance IS attributable to polygenetic differences among individuals. 
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-((J-l)/nt)(U;+4 components. The sum of the two variance components is fixed for this sample -so, if one goes up, the other must go down. The contribution of the apo E polymorphism to the variance of cholesterol, betalipoprotein and triglyceride levels is given in Table 4 . This contribution has been estimated using four different estimators : substituting parameters in equation (2) with parameter estimates, two bias corrected estimators, and the difference between the estimated polygenetic variance Components of the complete model and a model with no apo E effects parameterized. The proportion of the estimated genetic variance and phenotypic variance attributable to the apo E polymorphism estimated by each method are also given. The contribution of the apo E polymorphism to variability of cholesterol levels ranges from 6 5 yo to 8.8 yo, depending on the method used. We estimate that this polymorphism accounts for between 10.9 % and 14.7 yo of the genetic variance underlying cholesterol variability, depending on the method used. The apo E polymorphism accounts for between 3-8 yo and 8 %, and between 0.1 yo and 2.5% of the variability of betalipoprotein and triglyceride levels, respectively. No other loci have been identified with such a large contribution to the interindividual variability of a cardiovascular disease risk factor in the population a t large. I n ytwarai, t h c frc.qiwn(.y and d f w t s of the rrpo E polymorphism reported here are in accordance tilts of others (revie\\cd in Sing 8: Davignon. 1985; Boerwinkle ~t al. 19866 ). The rcsidual polj gc>netic. \ urianw accounts for 56" and 42 O 0 of the within apo E genotype variance of c*holt~stcw)l and hvt alipoprotcins. respecstivcly. So effect of the apo E polymorphism on triglyc.c~ritlc lex els M a. cletc.cAtcd. Vnmeasurctl polygenetic differences among individuals accwunt for 26.5 0 o of the intcrindividual variability of triglyceride levels. \Vit ti the r w i l t s 1)rewntetl here. ~e have begun to investigate the genetic architecture unt1erl.i ing csholrsterol bctalipoprotein and triglyceride variability. Using the estimated allele frcquc.nc*ics and the wtiinatetl genotype specific phenotypic means, we next calculated the avcrayr' d k c t s of the upo h' alleles on total cholcsterol. betalipoprotein and triglyceride levels ( Fig. 1 ) E'ormalac~ for estimating the averagcb effects of the apo E alleles have been previously prrsentd (Sing K. Ilavignon. 1985 : Boer\$ inkle et nl. 19866). The average effect of an apo E allele niay hc intcryrcbtcd as the avc'rage deviation from the sample mean of individuals carrying that allrlc Thc avc.ragt. effect of the €2 allele is to loacr cholesterol and betalipoprotein levels by 0,425 ~nmol/l and 0.81 1 units. respectively. The average effect of the e4 allele is to raise the level of thew phenotypes t)! 0.235 mmol/l and 0.628 units, respectively. The average effect of the 6,'s wllrl(. IS near zer 1. Tht. average effects of the npo E alleles on triglyceride levels are also near zcro. 'I'htw avc.ri*gc tfkcts of the npo h' alleles are similar to those reported for other populations (reviewed in Boerwinkle rt nl. 19866).
Tht. model given in equation (1) assumes that the average effects of an apo E allele are the same for all individuals carrying that allele. Our previous analyses have indicated that there is no evidence for statistically significant interaction between the effects of the apo E polymorphism and the effects of gender (Boerwinkle et al. 1986b ). The results reported here are the first time that the frequency and effects of the apo E polymorphism have been examined in a sample including children. We examine here whether the effects of the apo E polymorphism on total cholesterol levels are consistent between generations. To do this, we created two subsamples to compare. The first subsample consists of the parents of the families ( N = 204) and the second subsample consists of the youngest child from each family ( N = 101 ; recall that one 'family' was childless). Among the sample of parents, the average effects of the €2, €3 and €4 alleles are -0.54 mmoljl, 0.06 mmol/l and 0-24 mmol/l, respectively. Among the sample of children, the average effects of these alleles are -0*67,0*06 and 0.31 mmol/l, respectively. The distributional properties of the estimated vector of average effects of alleles are unknown and a method for testing the equality of a vector of average effects of alleles is not obvious. We used a sample-resample method, described in the appendix, to test the hypothesis that the average effects of the apo E alleles are equal between generations. We infer that the average effects of the apo E alleles are not statistically different between the parents and the youngest child of the families.
The variability among estimates of the contribution of the apo E polymorphism to the phenotypic variance presented in Table 4 is not large. For total plasma cholesterol levels, the contribution of the apo E polymorphism to the phenotypic variance ranged from 6.5 % to 8.8 yo.
It is not clear which estimator is more accurate. We know that the estimator derived directly from the parametric definition given in equation (2) is biased upward (Boerwinkle & Sing, 1986) . The two bias corrections applied here are intuitive and may not be the correct magnitude. The form of the bias correction is based on the bias correction appropriate for a sample of unrelated individuals (Boerwinkle & Sing, 1986) . The estimator based on the difference between polygenetic variance components may also be biased. Clearly, the problem of estimating the contribution of a single polymorphic locus to the determination of the polygenetic variance has yet to be adequately resolved.
One advantage of the measured genotype approach to quantitative phenotypic variability is that it creates a more complete picture of the sources of genetic variability contributing to the phenotype. A measured genotype approach yields critical information for elucidating the genetic architecture of quantitative phenotypic variability. Below, we summarize our understanding about the genetic architecture of total cholesterol variability. This understanding is developed from the work presented here, in the other papers in this series, and by the work of others. Ignoring the measured genotype information, we report here that 58% of the interindividual variability in adjusted cholesterol levels is attributable to genetic differences among individuals. This number is similar to that reported by others (Sing & Orr, 1978; Rao et al. 1979) . It is the goal of a measured genotype approach to partition this polygenetic variance contribution into the contribution of individual measured loci and residual unmeasured polygenes. In the present study, we estimate that about 7 yo of the variability of cholesterol levels among individuals is attributable to the apo E polymorphism. We also estimate that 56 74 of the within apo E genotype cholesterol variability is attributable to residual polygenetic effects. I n earlier studies (Boerwinkle et al. 1986b; Boerwinkle et al. 1987 ) using samples of unrelated adults, we reported that the apo E and apo A-I V polymorphisms account for 8.6 yo and 0.6 ",. respectively, of the interindividual variability in adjusted total cholesterol levels.
Talmud & Huniphries (1986) described an Xba I restriction fragment length polymorphism in the apo H gene that accounts for 18 "lo of the cholesterol variability in a sample of 61 individuals from London. Moll et al. (1986) have reported evidence from segregation analysis of the existence of a polymorphic locus with a major effect on apolipoprotein A-I levels that accounts for 1 Yo of thc variance of (.holesterol . 1975 ). This is not a cwmpletv list. Thcrc are likely other polymorphic loci whose products are involved in lipid metabolism. the t>ffects of which are not considered here. Assuming that there is no statisticd interaction hetween the effects of these loci, the combined contribution of these loci to the Interindividual variability of cholesterol levels is approximately 34 yo.
&At Icast tmo major points emerge from these studies. The first major point is that if the results reviekt t h d here give any indication of future directions, as more measured genotype analyses are caarricti out on a gircn phenotype. the sum of the contributions of individual loci to the phcnot? pic. variance may exceed the polygenetic variance component. The few loci discussed above account for approximately 34 9, of the phenotypic variance for total serum cholesterol 1evc.h A4ssuniing that 5 8 O , of the phenotypic variance can be accounted for by polygenetic among individuals, these loci account for 59 yo of the polygenetic variance. If the other l o c i have a contribution similar to the apo E and up0 A-IF' polymorphisms, it will only requirt. four or five more to account for all the genetic variability underlying cholesterol variability. HOES can this be so in light of the fact that there are likely many loci affecting cholesterol levelh IVv bclieve there arc four likely explanations. The first is that the samples revicmcrl abovv are hPterogeneous in such a way that the results cannot be pooled across studies. Although thia is likely the case, we believe that these few loci are still contributing to a very large fraction of thc plygenetic variance component. The second explanation is that the loci are interacting in such a way that the variance contribution by multiple loci is less than the sum of the variance contributions of individual loci. I n preliminary analyses of 188 unrelated individuals measured for the apo E polymorphism, apo A-Z V polymorphism, and plasma levels of cholesterol. bt.talipoprotein and triglycerides, we have detected no significant evidence for statistical interaction between the effects of these loci on the levels of these quantitative phmotypes (Hot.rwinklc & Sing, unpublished results). This does not preclude interaction between other 1oc.i. The third explanation is that the loci with moderate and large effects have all h c~n accountcd for and the remaining loci have very small contributions to the phenotypic varianw. The fourth explanation is that our methods of estimating the variance contribution of a single measured locus and the polygenetic variance component are incorrect and/or not comparable. Th(1 variance contribution of the single measured locus is calculated from its genotype frequencies and effects. The polygenetic variance component is a random effect estimated as a function of the covariance between relatives. The polygenetic model assumes there arc a largc number of unlinked loci, each with small effects so that, by the central limit t heortm. the polygenetic effects are normally distributed in the population with variance u : . Thc variance contribution by loci such as apo E is relatively large. How loci with large (fixed) effects contribute to the polygenetic (random) effects is not clear. By the very nature and assumptions of the traditional polygenetic model, it may 'not allow' one to partition out of the estimated polygenetic variance component the effects of individual loci with large contributions to the variance of the quantitative phenotype.
The second major point is that the majority of the genetic variability can be accounted for by polymorphic gene loci with moderate effects on the quantitative phenotype. The contribution to cholesterol variability by genes marked by ABO and other marker loci (Sing & Orr, 1976) is small because of their minuscule effects. Loci with very large effects on the individual, such as familial hypercholesterolemia and its effect on cholesterol levels (Goldstein & Brown, 1979) , for example, do not contribute greatly to the phenotypic variance in the population because of the rare frequency of the variant genotype. It is relevant for a discussion of the genetic architecture of a quantitative phenotype to distinguish between the relationship that exists between the effect o f a single locus on the level of the phenotype for an individual and the effect of the locus on the variance of the phenotype in the population a t large. We hypothesize that polymorphic loci in the population that have moderate effects on the level of the phenotype of an individual contribute to the majority of the genetic variance in the population. Thc average effect of an allele may be interpreted as the expected deviation from the population mean of an individual carrying that allele. Nost textbooks of quantitative genetics prescnt expressions for the average effects of alleles as a function of the genotype frequencies and phcnotype value (see for example, Kempthorne, 1969; Falconer, 1981) . In this paper, we calculate the average effect of the three up0 E alleles on total plasma cholesterol, betalipoprotein and trigly-ceride levels. The formula used here for estimating the average effect of an allele is equal t o \+hr.r<> zl is the average cffcct of the j t h allele, i are the other alleles at the locus, ,uij is the mean phcnotj.pic* lcvel of the ijth genotype. p. is the grand mean,ftj is the expected frequency of the ijth y t~n o t y p assuming Hardy-IVeinberg equilibrium and f, is the allele frequency of the j t h Fig. 2 . Frequency distribution of g(a) for total cholesterol levels over 5000 permutations of the data allele. For a given genetic system there are as many average effects of alleles as there are alleles at that locus. The average effects of alleles at a locus are subject to the restriction : Cfj aj = 0.
The statistical properties of the estimated average effects are not known. They are complicated functions of the estimated allele frequencies and genotype means. A method for testing hypotheses about the value of the average effects of alleles at a locus, or the equality of the average effects of the alleles a t a locus among groups is not obvious.
We propose and have applied a sampling-resampling approach to test the equality of a vector of average effects of alleles among groups. This approach is an extension of an approach suggested by Templeton et al. (1987) to test whether the average effects of the alleles at a locus arc statistically significantly different from zero. The statistic we propose is : where ajk is the average effect of the j t h allele in the kth group and a?. is the average effect of the j t h allele ignoring the groups. It is understood that the summation over the j alleles precedes the summation over the k groups. The distribution of this statistic is not known. The null distribution of the statistic may be approximated by calculating the value of the statistic from repeated sampling data under the null hypothesis (Efron, 1982). These repeated samples are generated from the sample of data to be tested by resampling without replacement from the data and allocating the observations randomly to the k groups. The overall genotypephenotype relationship (ix. the average effects of the alleles ignoring groups = ai.) and the size of thc k groups is preserved in these analyses. If the value of g ( a ) from the data exceeds the percentile of the null distribution of g ( a ) determined by the desired significance level, one rejects the null hypothcsis that the average effects of the alleles at this locus are the same among the k groups.
For the present application. we wished to determine whether the average effects of the up0 E= alleles are homogeneous among the parents and the youngest child from each family. We carriid out 5000 permutations of the data among groups before ar.y inference was made. We determined that 5000 permutations were sufficient for the distribu n of g ( a ) to stabilize. For total cholesterol levels. the value of g ( a ) for the data is 0-091. The sal ple frequency distribution of y(a) for thc 5000 permutations of the data under the null hypo hesis is given in Figure 2 . The cut-off values that determine the loth, 5th and 1st percentile of this distribution are 0.537, 0.647. 0.865. respectively. The statistic g(a) for the data does not exceed any of these significanc*e levels. Therefore. we infer that the average effects of the upo E alleles on total cholesterol levrls among the parents and the youngest child from each family are homogeneous.
The average efiects of the npo E alleles on betalipoprotein and triglyceride levels were also not statisticdly significantly different between these two groups. 
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